Afer US pharma giant Pfizer submitted its coronavirus vaccine, the US Food and Drug Administration (FDA) said its vaccines committee will meet on December 10 to discuss the request for emergency use authorization.

FDA sets December 10 meeting to discuss Pfizer's vaccine authorization bid

After announcing successful human trials of the coronavirus vaccine, the US biotech giant Pfizer and its German partner BioNTech have applied for immediate approval of the vaccine in the US.

Pfizer-BioNTech apply for COVID-19 vaccine approval in US

In August, the World Health Organisation(WHO) had said that a vaccine will be a "vital tool" in the global fight against the virus but it won't end the pandemic on its own.

Despite vaccine breakthrough, social distancing and wearing masks may remain

The year 2020 began with a grim atmosphere as the novel coronavirus took over the world, sending billions of people around the globe in a lockdown. The situation became worse as the year progressed and the world lost millions to the deadly virus.

Study claims COVID-19 immunity lasts at least six months; WHO signals hope

India is racing ahead with work on its coronavirus vaccine as countries around the world sought to conquer the pandemic and rescue their economies. Also read: These three Indian companies are ready to produce Covid-19 vaccine Companies like Zydus Cadila, Serum Institute and Bharat Biotech are at the forefront of research on covid vaccines and are likely to be among the leading manufacturers as and when their commercial application is permitted.

Oxford COVID-19 vaccine to be available for Indians by April 2021: Serum Institute Chief 

The United States top infectious disease official, Anthony Fauci, has vowed for the data of the two coronavirus vaccines being tested by Pfizer and Moderna. Fauci spoke at a briefing from White House virus task force to talk about the rising concerns about the credibility of the two vaccines, given their speed of testing.

Fauci guarantees accuracy in Pfizer, Moderna COVID-19 vaccine data

Pfizer and its partner BioNTech confirmed on Friday they have applied to US health regulators for emergency use authorisation (EUA) of its COVID-19 vaccine, becoming the first to do so in the US as the pandemic rages around the world.

Pfizer, BioNTech apply for emergency use of coronavirus vaccine in US

From Pfizer to Moderna, while vaccine makers are announcing efficacy rates of their shots - What do they mean for you? What's the next step? When will the vaccine finally reach you? WION's Molly Gambhir has the answers

Gravitas: Vaccine tracker

BioNTech announced on Wednesday that its potential coronavirus vaccine can come before Christmas if it secures emergency US and European authorisation. The final trial results of the vaccine co-developed by Pfizer and BioNTech have shown that it has a success rate of 95 per cent with no serious side effects and is effective for people belonging to all age groups.

Pfizer vaccine deliveries could begin before Christmas, if 'all goes well'

Pfizer Inc, after announcing that its vaccine is 90 per cent effective in preventing COVID-19 has now launched its first delivery programme for vaccines in the United States.

Pfizer to begin vaccine delivery programme in four US states

“Pfizer said it wasn’t part of Warp Speed, but that turned out to be an unfortunate misrepresentation," Trump added.

Trump claims credit for Pfizer vaccine effectivenes

Positive data on BioNTech and US partner Pfizer Inc's COVID-19 vaccine came as a happy surprise for not only the world, but also the married couple behind the German biotech firm. Physicians Ugur Sahin and Oezlem Tuereci, who bonded over their love of medical research, are the people behind the Covid-19 vaccine that could change the world.

Who is the couple behind Pfizer's COVID vaccine that could change the world?

After Pfizer's claim that the COVID-19 vaccine is more than 90% effective based on initial trial results, a few volunteers said that they suffered side effects comparable to a flu jab, with one comparing them to "a severe hangover".

Volunteers face 'severe hangover', headache and pain after getting Pfizer vaccine shot

As the coronavirus cases across the world continue to rise, World Health Organization(WHO) chief Tedros Adhanom Ghebreyesus said today that the UN health body is encouraged by "preliminary results of clinical trials released this week.

'World cannot put all eggs in one basket': WHO chief Tedros 'encouraged' by coronavirus clinical trials

Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential COVID-19 vaccine, and would soon begin making Novavax's rival shot, as they both seek regulatory approval.

India's Serum says made 40 million doses of AstraZeneca's COVID-19 vaccine

Israel signed a deal with Pfizer Inc on Friday to receive 8 million doses of the drugmaker`s potential COVID-19 vaccine, Prime Minister Benjamin Netanyahu said, enough to cover close to half of Israel`s population.

Israel signs deal with Pfizer for potential COVID-19 vaccine

The US and Europe are in line to get the first doses of an experimental coronavirus vaccine after a partnership between Pfizer Inc. and BioNTech SE delivered dazzling preliminary results in a large patient trial.

Countries queue for Pfizer's COVID-19 vaccine

U.S. infectious disease expert Anthony Fauci said on Thursday vaccine developers should push to make billions of their COVID-19 vaccines to ensure access to all parts of the world, instead of focusing on the rich countries.

Fauci hopeful about the prospects for a successful COVID-19 vaccine

Countries in line for Pfizer's COVID-19 vaccine

India is racing ahead with work on its coronavirus vaccine as countries around the world sought to conquer the pandemic and rescue their economies. Also read | Volunteers face 'severe hangover', headache and pain after getting Pfizer vaccine shot Companies like Zydus Cadila, Serum Institute and Bharat Biotech are at the forefront of research on covid vaccines and are likely to be among the leading manufacturers as and when their commercial application is permitted.

These three Indian companies are ready to produce Covid-19 vaccine

Pfizer Inc is currently in discussions with the government to distribute its potential COVID-19 vaccine in India. "We remain committed to advance our dialogue with the Government of India to make this vaccine available for use in the country," Indian media quoted the spokesperson as saying.

Pfizer in talks with government to bring its COVID-19 vaccine to India: Report

Pfizer CEO Albert Bourla sold $5.6 million of his stock in the US pharmaceutical company on the same day it announced promising results for its Covid-19 vaccine candidate, filings showed Wednesday.

Pfizer CEO sold $5.6 million in stock on the day of vaccine announcement 

Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many questions remain unanswered.

Pfizer COVID-19 vaccine: What does '90% effective' mean?

Work to distribute the experimental COVID-19 vaccine developed by Pfizer Inc and BioNTech SE is gearing up after the companies announced successful interim data earlier on Monday, but it will not be coming to local pharmacies for the general public any time soon.

Why Pfizer’s ultra-cold COVID-19 vaccine will not be at the local pharmacy any time soon

pfizer

Pfizer, News on Pfizer, stories on Pfizer, articles on Pfizer, Pfizer stories at Wion, Pfizer news, Pfizer latest news